HOME >> MEDICINE >> NEWS
New antibody profiling technique to test for lung cancer

Biomedical scientists have revealed a new and promising antibody profiling technique that provides a high degree of early diagnostic accuracy for non-small cell lung cancer cases.

Their research was reported in the second issue of November 2005 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.

Li Zong, Ph.D. of the Division of Pulmonary and Critical Care Medicine, Chandler Medical Center, University of Kentucky, Lexington, along with five associates, has identified five non-small cell lung cancer-associated antibody proteins that achieved 90 percent sensitivity and 95 percent specificity in identifying cancerous versus non-cancerous patient samples.

(Sensitivity indicates the probability that results will be positive when disease is present. Specificity identifies the probability that results will be negative when disease is absent.)

According to the U.S. National Cancer Institute, 160,000 people die each year from lung cancer, making it the number one cause of cancer death in America. Smoking is the primary cause of the disease.

The authors state that presently only 25 percent of new cases of lung cancer are diagnosed at an early stage, when curative surgery is possible.

"Serum tumor markers have the potential of being incorporated into diagnostic and therapeutic practice to improve historically dismal outcomes in non-small cell lung cancer," said Dr. Zong. "Potential uses include early detection or screening, differentiation of benign from malignant disease, differentiating histologies, defining stages and responses to therapy, and defining prognosis.

"These goals have generated considerable interest in identifying predictive tumor markers," Dr. Zong continues. "Although a number of non-small cell lung cancer tumor markers are measurable and a combination of markers can enhance diagnostic value, limited sensitivity and specificity of the
'"/>

Contact: Suzy Martin
smartin@thoracic.org
212-315-8631
American Thoracic Society
15-Nov-2005


Page: 1 2

Related medicine news :

1. Monoclonal antibody reduces exacerbations in asthmatics
2. Buckyballs boost antibodys chemotherapy payload
3. Combination therapy with a monocloncal antibody and a vaccine leads to tumor rejection
4. Clinical trial confirms novel EGFR antibody targets tumors but not normal tissues
5. Monoclonal antibody cures West Nile virus-infected mice
6. Dartmouths alternative breast imaging techniques sort abnormal from normal tissue
7. New technique effective in closing accidental colonoscopy wounds
8. Novel catheter technique successfully patches holes in the heart
9. A closer look inside our lungs -- Penn researchers develop 2 novel imaging techniques
10. African scientists will train at Emory University in latest drug discovery techniques
11. Imaging technique is highly accurate in diagnosing, locating pancreas defects in newborns

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... 2017 , ... Global Lyme Alliance (GLA), the leading 501(c)(3) ... today announced the appointment of Timothy J. Sellati, Ph.D. as its Chief Scientific ... 20 years of research experience with Lyme and other tick-borne diseases. He has ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      , ... wrong, run afoul of The Quality System Regulation (§820.250), and Devicemakers find themselves ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, Keeping Up ... , In the competitive world of drug and device marketing and promotion, drug ... FDA rules. , The FDA has issued two draft guidances that are the ...
(Date:9/21/2017)... ... , ... Bill Howe Plumbing’s mission is to create an employee friendly company, ... For over 37 years, they have operated with their mission at the foundation and ... Diego. They were chosen as the Best San Diego plumber in 2016, named a ...
(Date:9/21/2017)... ... September 21, 2017 , ... The New England Center for ... today the election of Yie-Hsin Hung to the Board of Directors. , “The ... of Directors. Ms. Hung is an invaluable addition to our team,” said Vincent Strully, ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
(Date:9/7/2017)... Sept. 7, 2017  Eli Lilly and Company ... to streamline operations to more efficiently focus resources ... cost structure. Global workforce reductions, including those from ... to impact approximately 3,500 positions. ... annualized savings of approximately $500 million that will ...
Breaking Medicine Technology:
Cached News: